Study of the Stability of Factor VIII Activity in Human Plasma for Fractionation When Modeling Deviations in the Storage and Transportation Temperature Conditions
The European Pharmacopoeia requires that the transportation and storage of human plasma for fractionation should be carried out at –20 °C or below, while allowing for some deviations in the temperature regime. The current Russian regulatory documentation requires the transportation and storage of pl...
Saved in:
Main Authors: | A. A. Gorodkov, A. L. Poptsov, A. L. Khokhryakov |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Ministry of Health of the Russian Federation. Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products»
2020-09-01
|
Series: | Биопрепараты: Профилактика, диагностика, лечение |
Subjects: | |
Online Access: | https://www.biopreparations.ru/jour/article/view/285 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Factor VIII products: key aspects of development, clinical research and use (part 1)
by: Zh. I. Avdeeva, et al.
Published: (2021-03-01) -
Therapeutic Plasma Exchange: Current and Emerging Applications to Mitigate Cellular Signaling in Disease
by: R. M. Imtiaz Karim Rony, et al.
Published: (2025-07-01) -
Factor VIII products: key aspects of development, clinical research and use (part 2)
by: Zh. I. Avdeeva, et al.
Published: (2021-07-01) -
Plasma spectroscopy : the influence of microwave and laser fields /
by: Oks, E. A. (Evgenibi Aleksandrovich)
Published: (1995) -
Effects of different storage temperatures and durations on the activity of coagulation factor Ⅷ and Ⅸ in whole blood
by: WANG Hehe, et al.
Published: (2025-06-01)